Gain Therapeutics (GANX US)

Gain Therapeutics, Inc. aspires to redefine drug discovery with its proprietary target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.